Piling on pressure for a costly ‘miracle’ drug
Mediawatch - A podcast by RNZ
Last year Newshub put its weight behind a campaign to fund a treatment for cystic fibrosis from the public purse even though the cost was sky-high and the US-based maker never applied to register it here. Newshub fired up the campaign again this week. What’s changed?
